Objective To perform a systematic review and meta-analysis comparing overall prostate
cancer detection rate and clinically-significant prostate cancer detection rate between MRI …

Background The increase in the use of multiparametric magnetic resonance imaging for the
detection of prostate cancer has led to the rapid adoption of MRI-guided biopsies (MRGBs) …

Objective To better assess the increased utilization of multiparametric magnetic resonance
imaging (mpMRI) and fusion biopsy of the prostate, we compared prostate cancer detection …

Simple Summary US-MRI fusion biopsy is established as a technique of reference for the
detection of clinically significative prostate cancer compared to the ultrasound “template” …

Objective To compare magnetic resonance imaging‐guided cognitive fusion‐targeted
biopsies versus computer‐software‐based fusion‐targeted biopsies in prostate biopsy …

Methods With a quality assurance waiver from the institutional review board, we identified a
cohort of men who underwent MRI-TRUS-CF and synchronous template biopsy from 2015 …

Objective To compare the detection rate of clinically significant cancer (CSCa) by magnetic
resonance imaging-targeted biopsy (MRI-TB) with that by standard systematic biopsy (SB) …

BACKGROUND The current study was conducted to evaluate the performance of magnetic
resonance (MR)‐ultrasound‐guided fusion biopsy in diagnosing clinically significant …

PURPOSE We aimed to evaluate the efficacy of magnetic resonance imaging (MRI)-directed
cognitive fusion transrectal ultrasonography (TRUS)-guided anterior prostate biopsy for …

Context The current standard for diagnosing prostate cancer in men at risk relies on a
transrectal ultrasound–guided biopsy test that is blind to the location of the cancer. To …